DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Medicamen Biotech Limited — Outcome of Board Meeting

NSE 2 hrs ago·14 Aug 2026, 10:09 am

Medicamen Biotech

Medicamen Biotech Limited has informed the stock exchange about its financial results for the period ending June 30, 2026. The company has submitted these details to comply with regulatory disclosure norms.

For investors, this update is a key milestone as it provides the latest financial performance data. It allows shareholders to assess the company's current operational health and financial standing before the official announcement.

Investors should watch for the official release of the detailed financial statements. This will provide a clearer picture of the company's revenue, expenses, and profitability for the period in question.